Laura Hester

710 total citations
32 papers, 231 citations indexed

About

Laura Hester is a scholar working on Hematology, Epidemiology and Oncology. According to data from OpenAlex, Laura Hester has authored 32 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Laura Hester's work include Multiple Myeloma Research and Treatments (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers) and Pancreatitis Pathology and Treatment (4 papers). Laura Hester is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers) and Pancreatitis Pathology and Treatment (4 papers). Laura Hester collaborates with scholars based in United States, Netherlands and Sweden. Laura Hester's co-authors include Mugdha Gokhale, Jessie K. Edwards, Catherine R. Lesko, Carl A. Latkin, Clark McCauley, Jennifer L. Lund, Pamela Y. Collins, Til Stürmer‎, Geetanjali Chander and Melissa Davey‐Rothwell and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Laura Hester

27 papers receiving 220 citations

Peers

Countries citing papers authored by Laura Hester

Since Specialization

Citations

This map shows the geographic impact of Laura Hester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Hester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Hester more than expected).

Fields of papers citing papers by Laura Hester

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Hester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Hester. The network helps show where Laura Hester may publish in the future.

Co-authorship network of co-authors of Laura Hester

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Hester. A scholar is included among the top collaborators of Laura Hester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Hester. Laura Hester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	All Lines Is the Right Approach: Selecting Patient Lines of Therapy for an External Comparator Arm 2025 ·Pharmacoepidemiology and Drug Safety ·Daniel Backenroth, Laura Hester, Stijn Vansteelandt	0
2	Real-World Patient Characteristics and Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Receiving Teclistamab across Community Oncology Practices in the US 2024 ·Blood ·Binod Dhakal, Nina Kim, William S. John, Bingcao Wu, Sarah Lucht, Dee Lin, (unknown), (unknown), Bryce Van Doren, Laura Hester, (unknown), (unknown), (unknown), (unknown), Andrew J. Klink, (unknown), Bruce A. Feinberg, (unknown), (unknown), Peter M. Voorhees	1
3	Important tool in our rare disease toolbox: hybrid retrospective-prospective natural history studies serve well as external comparators for rare disease studies 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Joan Largent, (unknown), Laura Hester, Sareh Keshavarzi, Stuart Turner, (unknown)	1
4	Dosing Patterns and Early Safety and Effectiveness Outcomes in Patients with Multiple Myeloma Treated with Teclistamab in the Community Setting 2024 ·Blood ·Tomasz M. Beer, (unknown), Dee Lin, (unknown), (unknown), Laura Hester, Bingcao Wu, (unknown)	1
5	Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapy 2024 ·Pharmacology Research & Perspectives ·Scott F. Huntington, Dee Lin, Marie‐Hélène Lafeuille, Philippe Thompson‐Leduc, Aditi Shah, Nina Kim, Laura Hester, (unknown), (unknown), (unknown), (unknown), Xinke Zhang, Dina Gifkins, Bingcao Wu	0
6	Real-World Characteristics, Step-up Dosing Patterns, and Outcomes in Patients with Multiple Myeloma Receiving Teclistamab at Texas Oncology Community-Based Treatment Centers 2024 ·Blood ·Yair Levy, Nina Kim, (unknown), Bingcao Wu, (unknown), Dee Lin, Monica Lisi, (unknown), (unknown), (unknown), Laura Hester, (unknown), (unknown), (unknown), (unknown)	0
7	Real-World Characteristics and Outcomes in Patients with Multiple Myeloma Receiving Teclistamab Step-up Doses in Academic Vs. Community Settings 2024 ·Blood ·Aimaz Afrough, (unknown), (unknown), Nina Kim, Jinghua He, (unknown), Bingcao Wu, Dee Lin, (unknown), Laura Hester, (unknown), (unknown), (unknown), Larry D. Anderson	0
8	MM-344 Real-World Patient Profile and Step-Up Dosing Process of Early Initiators of Teclistamab for Multiple Myeloma (MM) in a Hospital Setting in the US: Premier Healthcare Database Study 2023 ·Clinical Lymphoma Myeloma & Leukemia ·Carlyn Tan, (unknown), Nina Kim, Laura Hester, (unknown), Dina Gifkins, Dee Lin, (unknown), Alex Z. Fu, Bingcao Wu	1
9	Update on prevalence of diagnosed systemic lupus erythematosus (SLE) by major health insurance types in the US in 2016 2022 ·BMC Research Notes ·(unknown), Laura Hester, Jennifer H. Lofland, Shawn Rose, Chetan S. Karyekar, David M. Kern, (unknown), Kourtney J. Davis, (unknown)	2
10	Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study 2020 ·Current Medical Research and Opinion ·Žhong Yuan, Frank DeFalco, (unknown), Laura Hester, James Weaver, Joel N. Swerdel, (unknown), Patrick Ryan, Martijn J. Schuemie, R. Qiu, Jacqueline Yee, Gary Meininger, Jesse A. Berlin, Norman Rosenthal	3
11	DIAGNOSTIC DELAY AND CHARACTERIZATION OF THE CLINICAL PRODROME IN AL AMYLOIDOSIS RELATED CARDIOMYOPATHY AMONG 1,173 PATIENTS DIAGNOSED BETWEEN 2001-2018 2020 ·Journal of the American College of Cardiology ·Laura Hester, Dina Gifkins, Kevin M. Bellew, Jessica Vermeulen, Jordan M. Schecter, John Strony, Brendan M. Weiss	1
12	Diagnostic Delay and Characterization of the Clinical Prodrome in AL Amyloidosis: Data from 1,313 US Commercially Insured Patients between 2006-2018 2019 ·Blood ·Laura Hester, Dina Gifkins, Kevin M. Bellew, Jessica Vermeulen, Jordan M. Schecter, Frank DeFalco, Brendan M. Weiss	2
13	Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co‐transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases 2019 ·Pharmacoepidemiology and Drug Safety ·(unknown), Erica A. Voss, James Weaver, Laura Hester, Žhong Yuan, Frank DeFalco, Martijn J. Schuemie, Patrick Ryan, (unknown), (unknown), Maria Alba, (unknown), Gary Meininger, Jesse A. Berlin, Norman Rosenthal	38
14	Publication of comparative effectiveness research has not increased in high-impact medical journals, 2004-2013 2017 ·Journal of Clinical Epidemiology ·Laura Hester, Charles Poole, Elizabeth A. Suarez, (unknown), (unknown), (unknown), (unknown), M. Alan Brookhart	1
15	Methodologic Issues when Estimating Risks in Pharmacoepidemiology 2016 ·Current Epidemiology Reports ·Jessie K. Edwards, Laura Hester, Mugdha Gokhale, Catherine R. Lesko	33
16	Patterns of comorbidity among older U.S. patients with non-Hodgkin lymphoma. 2016 ·Journal of Clinical Oncology ·Laura Hester, Steven I. Park, Jennifer L. Lund	1
17	Roles of the State Asthma Program in Implementing Multicomponent, School‐Based Asthma Interventions 2013 ·Journal of School Health ·Laura Hester, Maureen Wilce, (unknown), (unknown), Pamela Y. Collins, Gregory B. Crawford	13
18	An Examination of Spatial Concentrations of Sex Exchange and Sex Exchange Norms Among Drug Users in Baltimore, Maryland 2012 ·Annals of the Association of American Geographers ·Karin E. Tobin, Laura Hester, (unknown), Carl A. Latkin	11
19	Characterizing the geographic variation and risk factors of fatal prescription opioid poisoning in New Hampshire, 2003–2007 2012 ·Annals of GIS ·Laura Hester, Xun Shi, Nancy E. Morden	9
20	Social Network Characteristics and Heavy Episodic Drinking Among Women at Risk for HIV/Sexually Transmitted Infections 2011 ·Journal of Studies on Alcohol and Drugs ·Melissa Davey‐Rothwell, Geetanjali Chander, Laura Hester, Carl A. Latkin	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact